✦ LIBER ✦

576 Peginterferon α-2a (40 kDa) plus ribavirin in cirrhotic patients with chronic hepatitis C: Results of a Canadian multicenter open-label expanded access program

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

603 Peginterferon α-2a (40 kDa) plus rib

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

The economics of treating chronic hepati

✍ J. Hornberger; P. Farci; D. Prati; S. Zeuzem; J. Green; K. K. Patel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

[615] MANAGEMENT OF CHRONIC HEPATITIS C

✍ M. Deschenes; E. Yoshida; K. Peltekian; C. Cooper; V. Bain; M. Krajden; M. Sherm 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 264 KB

562 Age and sustained virological respon

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 116 KB

The treatment of chronic hepatitis C wit

✍ Maria Rendina; Antonio Schena; Nicola Maurizio Castellaneta; Francesco Losito; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 135 KB

612 Prediction of sustained virological

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB